LMO4 Antibody (LS-B2619)

貨號 Cat. No.
LS-B2619
規格 Size
50 µg
品牌 Brand
LSBio

Description





















































































Antibody Catalog ID: LS-B2619
Antibody Validation: This antibody replaces catalog number LS-C8523. It has been validated for use in the following assays: IHC-P.
Antibody Target: LIM Domain Only 4 (LMO4)
Synonyms: LMO4, breast tumor autoantigen, LMO-4
Host: LMO4 antibody was produced in Rabbit
Antigen Species: LMO4 antibody was raised against Human
Clonality: Polyclonal
Isotype: IgG
Antigen Type: Synthetic peptide
Immunogen: LMO4 antibody was raised against synthetic peptide corresponding to aa115-127 of human LMO4.
Antibody Specificity: Recognizes LMO4. Species cross-reactivity: Human and rodent.
Antigen Modification: aa115-127
Predicted Species Reactivity: Rodents
Purification: Affinity Chromatography
Presentation: PBS, pH 7.2. No preservative added.
Recommended Storage: +4°C or -20°C, Avoid repeated freezing and thawing.
Antibody Usage Summary: Immunohistochemistry: LS-B2619 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody LS-D1, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B2619 was determined to be 5 ug/ml.
Antibody Uses: Immunohistochemistry - Paraffin (IHC-P) (5 µg/ml), Immunohistochemistry - Frozen (IHC-Fr) (1:200 - 1:1000), Western blot (WB) (1:200 - 1:1000), ELISA (Optimal dilution to be determined by the researcher)
Size: 50 µg
Concentration: 1 mg/ml

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢